ANI PharmaceuticalsANIP
那斯達克 · USD
83.90
-1.87
(-2.18%)
盤中 01/22 01:08 (UTC+8)
01/22 01:08 (UTC+8)
ANI PharmaceuticalsANIP
83.90
-1.87
(-2.18%)
財務數據
損益表
- 1.17
- 1.32
- 1.32
- 1.37
- 1.38
- 1.48
- 1.91
- 1.97
- 2.11
- 2.28
- 9.14
- 13.11
- -0.13
- 4.39
- 0.44
- 7.46
- 28.48
- 3.44
- 7.23
- 7.78
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 227,813 | 211,371 | 197,122 | 190,574 | 148,332 | 138,040 | 137,430 | 131,654 | 131,829 | 116,547 |
營業成本 | 93,389 | 74,615 | 73,037 | 80,280 | 63,075 | 57,698 | 49,157 | 53,420 | 48,101 | 42,284 |
營業毛利 | 134,424 | 136,756 | 124,085 | 110,294 | 85,257 | 80,342 | 88,273 | 78,234 | 83,728 | 74,263 |
營業費用 | 97,889 | 122,864 | 97,891 | 114,672 | - | - | - | 71,508 | 65,780 | 61,861 |
研發費用 | 12,304 | 16,535 | 10,564 | 16,646 | 10,128 | 7,296 | 10,511 | 9,867 | 11,121 | 7,374 |
推銷及管理費用 | 62,186 | 83,048 | 64,436 | 67,826 | 79,900 | 53,180 | 48,111 | 46,447 | 39,452 | 39,795 |
非經常性項目費用 | 767 | - | - | 7,600 | - | - | - | - | - | 2 |
其他營業費用 | 22,632 | 23,281 | 22,891 | 22,600 | 15,748 | 14,697 | 14,686 | 15,194 | 15,207 | 14,690 |
營業利益 | 36,240 | 13,892 | 26,194 | -4,378 | -20,519 | 5,169 | 20,312 | 6,726 | 17,948 | 12,402 |
其他收入及費用 | -1,148 | 1,739 | 198 | -1,378 | -10,003 | -88 | 5,315 | -33 | -39 | -53 |
利息費用 | 4,727 | 5,438 | 5,484 | 6,015 | 2,331 | 4,656 | 4,600 | 5,746 | 6,398 | 7,100 |
稅前純益 | 33,800 | 10,525 | 19,987 | -13,762 | -31,498 | -2,287 | 25,335 | 947 | 11,511 | 5,249 |
所得稅 | 7,183 | 1,976 | 4,306 | -3,486 | -7,332 | - | 7,128 | -208 | 1,571 | -996 |
稅後純益 | 26,617 | 8,549 | 15,681 | -10,276 | -24,166 | -2,287 | 18,207 | 1,155 | 9,940 | 6,245 |
基本每股稅後盈餘(元) | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 | - | 0.46 | 0.30 |
稀釋每股稅後盈餘(元) | 1.10 | 0.36 | 0.69 | -0.55 | -1.19 | -0.12 | 0.82 | 0.02 | 0.47 | 0.30 |
基本平均股數(千股) | 20074.00 | 19834.00 | 19607.00 | 19445.00 | 19404.00 | 19321.00 | 19099.00 | - | 18883.00 | 17688.00 |
稀釋平均股數(千股) | 21093.00 | 20308.00 | 20046.00 | 19445.00 | 19404.00 | 19321.00 | 19422.00 | - | 19125.00 | 17855.00 |
還原基本每股稅後盈餘(元) | 1.19 | 0.37 | 0.70 | -0.55 | -1.27 | -0.14 | 0.84 | - | 0.46 | 0.30 |
還原稀釋每股稅後盈餘(元) | 1.10 | 0.36 | 0.69 | -0.55 | -1.19 | -0.12 | 0.82 | 0.02 | 0.47 | 0.30 |
還原基本平均股數(千股) | 20,074 | 19,834 | 19,607 | 19,445 | 19,404 | 19,321 | 19,099 | - | 18,883 | 17,688 |
還原稀釋平均股數(千股) | 21,093 | 20,308 | 20,046 | 19,445 | 19,404 | 19,321 | 19,422 | - | 19,125 | 17,855 |
EBITDA(千元) | 61,159 | 39,244 | 48,362 | 25,228 | -10,195 | 17,066 | 44,621 | 21,887 | 33,116 | 27,039 |